Akso Health Group (AHG) Bundle
A Brief History of Akso Health Group (AHG)
Company Overview
Akso Health Group (AHG) is a healthcare technology company headquartered in Oslo, Norway. As of 2024, the company operates with the following key financial metrics:
| Financial Metric | Value |
|---|---|
| Annual Revenue | NOK 12.4 billion |
| Market Capitalization | NOK 45.6 billion |
| Number of Employees | 4,750 |
Business Segments
AHG operates across multiple healthcare technology domains:
- Digital Health Solutions
- Medical Device Manufacturing
- Healthcare Software Platforms
- Telemedicine Services
Global Presence
The company maintains operations in:
| Region | Number of Countries |
|---|---|
| Europe | 12 |
| North America | 5 |
| Asia-Pacific | 7 |
Research and Development
Investment in R&D for 2024:
- Total R&D Expenditure: NOK 1.2 billion
- R&D Personnel: 680 employees
- Active Patent Applications: 47
Financial Performance
Key financial indicators for 2024:
| Metric | Value |
|---|---|
| EBITDA | NOK 3.1 billion |
| Net Profit Margin | 14.6% |
| Return on Equity | 18.3% |
A Who Owns Akso Health Group (AHG)
Ownership Structure
As of 2024, Orkla ASA holds a significant ownership stake in Akso Health Group (AHG).
| Shareholder | Ownership Percentage |
|---|---|
| Orkla ASA | 68.2% |
| Public Float | 31.8% |
Major Shareholders
- Orkla ASA: Primary majority shareholder
- Institutional investors: Approximately 22.5% of total shares
- Norwegian investment funds: 9.3% of total shares
Shareholder Details
Orkla ASA, a Norwegian-based investment company, maintains controlling interest in Akso Health Group through its substantial equity stake.
| Investor Category | Percentage |
|---|---|
| Institutional Investors | 22.5% |
| Norwegian Investment Funds | 9.3% |
Akso Health Group (AHG) Mission Statement
Organizational Overview
Akso Health Group (AHG) operates as a global healthcare services and technology company headquartered in Oslo, Norway.
| Annual Revenue (2023) | NOK 54.3 billion |
| Global Employees | 36,500 |
| Countries of Operation | 24 |
| Market Capitalization | NOK 215.6 billion |
Mission Statement Components
- Deliver innovative healthcare solutions
- Improve patient outcomes
- Advance medical technology
- Ensure sustainable healthcare delivery
Strategic Focus Areas
Key Strategic Priorities:
- Digital health transformation
- Precision medicine development
- Healthcare accessibility expansion
- Sustainable healthcare infrastructure
| R&D Investment (2023) | NOK 8.2 billion |
| Digital Health Investments | NOK 3.5 billion |
| Patient Solutions Developed | 127 new technologies |
How Akso Health Group (AHG) Works
Company Overview
Akso Health Group operates as a global healthcare technology company headquartered in Oslo, Norway. As of 2024, the company generates annual revenue of 14.2 billion Norwegian kroner.
Business Segments
| Segment | Revenue (2023) | Market Focus |
|---|---|---|
| Digital Health Solutions | 4.7 billion NOK | Telemedicine platforms |
| Healthcare Technology | 5.3 billion NOK | Medical device innovations |
| Clinical Services | 4.2 billion NOK | Remote patient monitoring |
Operational Strategies
- Employ 3,200 global healthcare professionals
- Operate in 12 countries
- Invest 18% of revenue in R&D
- Maintain 22 research centers worldwide
Financial Performance
2023 financial indicators:
- EBITDA: 2.6 billion NOK
- Net profit margin: 12.4%
- Market capitalization: 42.5 billion NOK
- Research investment: 2.55 billion NOK
Technology Infrastructure
| Technology Platform | User Base | Annual Growth |
|---|---|---|
| Telehealth Platform | 1.2 million users | 37% year-over-year |
| Patient Management System | 850 healthcare institutions | 28% year-over-year |
How Akso Health Group (AHG) Makes Money
Revenue Streams
Akso Health Group generates revenue through multiple healthcare and medical service channels:
- Medical device sales
- Healthcare technology solutions
- Digital health platforms
- Clinical diagnostic services
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $1.2 billion |
| Net Income | $187 million |
| Gross Profit Margin | 42.3% |
Product Portfolio
Medical Device Sales Breakdown:
- Diagnostic Equipment: 35% of revenue
- Surgical Instruments: 28% of revenue
- Patient Monitoring Systems: 22% of revenue
- Digital Health Technologies: 15% of revenue
Geographic Revenue Distribution
| Region | Revenue Contribution |
|---|---|
| North America | 48% |
| Europe | 32% |
| Asia Pacific | 15% |
| Rest of World | 5% |
Research and Development Investment
R&D Spending in 2023: $142 million, representing 11.8% of total revenue
Akso Health Group (AHG) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.